Guaifenesin 46122-0750-51
- Manufacturer
- Amerisource Bergen
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- August 11, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA209254
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Selected Package
46122-0750-51Selected2 BLISTER PACK in 1 CARTON (46122-750-51) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK